Bo Lin

1.1k total citations
36 papers, 753 citations indexed

About

Bo Lin is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Bo Lin has authored 36 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Bo Lin's work include Thyroid Cancer Diagnosis and Treatment (9 papers), BRCA gene mutations in cancer (6 papers) and DNA Repair Mechanisms (3 papers). Bo Lin is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (9 papers), BRCA gene mutations in cancer (6 papers) and DNA Repair Mechanisms (3 papers). Bo Lin collaborates with scholars based in China, United States and Ethiopia. Bo Lin's co-authors include Zhaoqing Fan, Weiming Lv, Tao Fan, Yuntao Xie, Ye Xu, Tao Ouyang, Maoguang Ma, Tao Ouyang, Zicheng Sun and Jie Li and has published in prestigious journals such as Endocrinology, Journal of neurosurgery and British Journal of Cancer.

In The Last Decade

Bo Lin

35 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Lin China 14 264 258 219 215 144 36 753
Craig Luccarini United Kingdom 13 225 0.9× 296 1.1× 167 0.8× 435 2.0× 164 1.1× 23 948
Chika Tazawa Japan 11 165 0.6× 242 0.9× 135 0.6× 131 0.6× 58 0.4× 15 561
Ricardo Chirino Spain 16 103 0.4× 210 0.8× 203 0.9× 183 0.9× 98 0.7× 36 587
Joel Mefford United States 15 231 0.9× 194 0.8× 43 0.2× 282 1.3× 98 0.7× 35 767
Nobuaki Ohtake Japan 17 139 0.5× 192 0.7× 105 0.5× 369 1.7× 124 0.9× 47 726
Yvette N. Martin United States 13 129 0.5× 121 0.5× 116 0.5× 139 0.6× 112 0.8× 19 769
Phillip J. Stella United States 13 685 2.6× 134 0.5× 139 0.6× 384 1.8× 192 1.3× 19 1.2k
Gavin Lucas Spain 14 235 0.9× 129 0.5× 84 0.4× 242 1.1× 58 0.4× 22 710
L. Demers United States 12 504 1.9× 208 0.8× 162 0.7× 283 1.3× 132 0.9× 18 1.0k
Thomas J. Worgul United States 13 173 0.7× 384 1.5× 257 1.2× 131 0.6× 102 0.7× 19 730

Countries citing papers authored by Bo Lin

Since Specialization
Citations

This map shows the geographic impact of Bo Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Lin more than expected).

Fields of papers citing papers by Bo Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Lin. The network helps show where Bo Lin may publish in the future.

Co-authorship network of co-authors of Bo Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Lin. A scholar is included among the top collaborators of Bo Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Lin. Bo Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huo, Zijun, Jin Li, Bo Lin, et al.. (2025). CircPSD3 aggravates tumor progression by maintaining TCA cycle and mitochondrial function via regulating SUCLG2 in thyroid carcinoma. Cell Death and Disease. 16(1). 590–590.
2.
Chen, Gang, Jianyan Long, Dandan Xiong, et al.. (2024). The impact of preoperative calcitonin screening on the prognosis of patients with medullary thyroid cancer: a retrospective multicenter cohort study. Endocrine. 85(2). 827–836. 3 indexed citations
3.
Feng, Yanhui, Juan Xiong, Ge Lin, et al.. (2024). Exploring IAA biosynthesis and plant growth promotion mechanism for tomato root endophytes with incomplete IAA synthesis pathways. Chemical and Biological Technologies in Agriculture. 11(1). 7 indexed citations
4.
5.
Yang, Rui, Ruixia Li, Jing Zhang, et al.. (2023). Exploring the Association Between Thyroid Function and Oral Microbiome Diversity: An NHANES Analysis. Journal of the Endocrine Society. 7(11). bvad125–bvad125. 11 indexed citations
6.
He, Weiman, Zhen Cheng, Zijun Huo, et al.. (2023). STRA6 Promotes Thyroid Carcinoma Progression via Activation of the ILK/AKT/mTOR Axis in Cells and Female Nude Mice. Endocrinology. 164(3). 3 indexed citations
7.
Wang, Zhecun, Jing Zhang, Ruixia Li, et al.. (2023). The interference between effects of PFAS exposure on thyroid hormone disorders and cholesterol levels: an NHANES analysis. Environmental Science and Pollution Research. 30(39). 90949–90959. 17 indexed citations
8.
Liu, Yihao, Fenghua Lai, Bo Lin, et al.. (2023). Deep learning to predict cervical lymph node metastasis from intraoperative frozen section of tumour in papillary thyroid carcinoma: a multicentre diagnostic study. EClinicalMedicine. 60. 102007–102007. 8 indexed citations
9.
Yao, Meng, Xiaogang Shen, Quanquan Shen, et al.. (2023). Aspirin intervention before ICU admission reduced the mortality in critically ill patients with acute kidney injury: results from the MIMIC-IV. Frontiers in Pharmacology. 14. 1292745–1292745. 3 indexed citations
10.
Goto, Kōichi, J. Wolf, Yasir Y. Elamin, et al.. (2021). FP14.05 LIBRETTO-431: Selpercatinib in Treatment-Naïve Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC).. Journal of Thoracic Oncology. 16(3). S228–S229. 5 indexed citations
11.
Ma, Maoguang, Zhanqiang Zhang, Bo Lin, et al.. (2021). Apolipoprotein A1 is negatively associated with male papillary thyroid cancer patients: a cross-sectional study of single academic center in China. BMC Endocrine Disorders. 21(1). 69–69. 6 indexed citations
12.
Hernando, Jorge, Mimi I. Hu, Eric J. Sherman, et al.. (2020). 1927TiP LIBRETTO-531: Selpercatinib in patients with treatment (Tx)-naïve RET-mutant medullary thyroid cancer (MTC). Annals of Oncology. 31. S1091–S1091. 3 indexed citations
13.
Liu, Yihao, Бин Ли, Qiuyi Zheng, et al.. (2020). The Current Landscape of Clinical Studies Focusing on Thyroid Cancer: A Comprehensive Analysis of Study Characteristics and Their Publication Status. Frontiers in Endocrinology. 11. 575799–575799. 6 indexed citations
14.
Lin, Bo, Bing Lu, Zhen Liang, et al.. (2020). Synergy of GSK-J4 With Doxorubicin in KRAS-Mutant Anaplastic Thyroid Cancer. Frontiers in Pharmacology. 11. 632–632. 9 indexed citations
15.
He, Jincan, Bo Lin, Zhen Liang, et al.. (2019). H3K27me3 loss plays a vital role in CEMIP mediated carcinogenesis and progression of breast cancer with poor prognosis. Biomedicine & Pharmacotherapy. 123. 109728–109728. 30 indexed citations
16.
Ouyang, Tao, et al.. (2018). Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancers. Annals of Oncology. 29(10). 2046–2051. 24 indexed citations
17.
18.
Lin, Bo, et al.. (2015). Preoperative Percutaneous Nerve Mapping of the Mandibular Marginal Branch of the Facial Nerve. Journal of Craniofacial Surgery. 26(2). 411–414. 5 indexed citations
19.
Xu, Ye, Tao Ouyang, Zhaoqing Fan, et al.. (2014). Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer. Annals of Oncology. 25(6). 1158–1164. 37 indexed citations
20.
Xu, Ye, Yu Sun, Lei Yao, et al.. (2008). Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment. Annals of Oncology. 19(8). 1423–1429. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig Luccarini Breakdown of academic impact, for papers by Chika Tazawa Breakdown of academic impact, for papers by Ricardo Chirino Breakdown of academic impact, for papers by Joel Mefford Breakdown of academic impact, for papers by Nobuaki Ohtake Breakdown of academic impact, for papers by Yvette N. Martin Breakdown of academic impact, for papers by Phillip J. Stella Breakdown of academic impact, for papers by Gavin Lucas Breakdown of academic impact, for papers by L. Demers Breakdown of academic impact, for papers by Thomas J. Worgul
Rankless by CCL
2026